Position in LH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$783,440
-$2,200,563 QoQ
Shares Held
2,798
-75.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#499
of 1,040 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Bridgewater Associates, LP holds $63,888,573 across 17 Diagnostics & Research names. LH ranks #14 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IDXX |
Idexx Laboratories Inc /De
|
33,528 | $17,650,480 | |
| 2 | MEDP |
Medpace Holdings, Inc.
|
15,605 | $8,264,251 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
12,948 | $6,491,609 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
26,210 | $5,064,296 | |
| 5 | DHR |
Danaher Corp /De/
|
25,684 | $4,892,288 | |
| 6 | MTD |
Mettler Toledo International Inc/
|
3,146 | $4,019,046 | |
| 7 | VCYT |
Veracyte, Inc.
|
58,289 | $3,423,312 | |
| 8 | A |
Agilent Technologies, Inc.
|
22,889 | $3,040,345 |
All Filings in LH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $783,440 | 2,798 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,984,003 | 11,184 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,356,782 | 17,366 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,983,414 | 10,393 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $727,415 | 2,771 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $4,201,189 | 18,051 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $8,359,172 | 36,452 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $33,494,735 | 149,878 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $42,230,360 | 207,510 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||